PharVision Advisers’s Kodak KODK Stock Holding History

PharVision Advisers’s Portfolio KODK Stock Details KODK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-11,743	Closed	-$106K	–	98
2026 Q1	$106K	Sell	11,743 -21,268	-64%	-$162K	1.08%	44
2025 Q4	$279K	Buy	33,011 +20,259	+159%	+$151K	0.14%	313
2025 Q3	$81.7K	Buy	+12,752	New	+$80.3K	0.05%	636

Other funds holding KODK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

PharVision Advisers's KODK Position: Q2 2026 in Review

PharVision Advisers sold out of Kodak (KODK) in Q2 2026, closing a stake of 11,743 shares — an estimated $106K sold.

PharVision Advisers first reported a position in KODK in Q3 2025 and held it in 3 quarters. The position peaked at $279K in Q4 2025. 179 funds tracked by Wall St. Rank hold KODK as of Q2 2026.

PharVision Advisers reported no remaining Kodak position as of Q2 2026 after selling out during the quarter.
PharVision Advisers sold 11,743 Kodak shares in Q2 2026, an estimated $106K.
PharVision Advisers first reported a position in Kodak in Q3 2025 and held it in 3 quarters.
PharVision Advisers's Kodak position peaked at $279K in Q4 2025.
179 funds tracked by Wall St. Rank held Kodak as of Q2 2026.

Based on PharVision Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.